The role of atrial fibrillation catheter ablation in patients with heart failure.
Atrial Fibrillation
Catheter Ablation
Heart Failure with reduced Ejection Fraction
Journal
Progress in cardiovascular diseases
ISSN: 1873-1740
Titre abrégé: Prog Cardiovasc Dis
Pays: United States
ID NLM: 0376442
Informations de publication
Date de publication:
Historique:
entrez:
1
8
2021
pubmed:
2
8
2021
medline:
31
8
2021
Statut:
ppublish
Résumé
Atrial Fibrillation (AF) and heart failure (HF) with reduced ejection fraction (HFrEF) frequently coexist, resulting in significant morbidity and mortality. Therapeutic options for patients with AF and HFrEF are limited due to few antiarrhythmic drug (AAD) choices and historically equivocal effects of procedural interventions on mortality. However, recent randomized trials examining catheter ablation (CA) in AF patients with HFrEF have shown a beneficial effect on arrhythmic burden and HF symptoms, as well as an improvement in mortality. This review focuses on the role of CA for AF patients with HFrEF.
Identifiants
pubmed: 34332663
pii: S0033-0620(21)00053-0
doi: 10.1016/j.pcad.2021.06.002
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
80-85Informations de copyright
Copyright © 2021. Published by Elsevier Inc.